Human papillomavirus type 1 (HPV1) virions, both as intact virion particles (IVP) and as detergentdenatured virions (DDV), were used to prepare polyclonal antisera and monoclonal antibodies (MAbs) reading frames (ORFs), respectively, because they react specifically with antisera generated against Liand L2-encoded recombinant proteins, respectively (7). The predicted size of an Li-encoded polypeptide is 57 kDa, which is consistent with the observed mobility of the major capsid protein upon sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). The predicted size of an L2-encoded polypeptide is 55 kDa. However, the observed mobility of the minor capsid protein has been reported to be between 76 and 86 kDa. It is unclear whether the observed mobility of the minor capsid protein is due to an inherent property of the L2-encoded polypeptide which causes it to migrate aberrantly upon SDS-PAGE or whether it is due to the addition of high-molecular-weight moieties to the L2 polypeptide through posttranslational modification.
Human papillomavirus (HPV) virions are nonenveloped icosahedral particles which are 55 nm in diameter (21). Virion capsids are composed of at least two viral proteins, a major capsid protein (53 to 57 kDa) and a minor capsid protein (76 to 86 kDa). At least some if not all of the major and the minor capsid proteins are encoded by the HPV Li and L2 open reading frames (ORFs), respectively, because they react specifically with antisera generated against Liand L2-encoded recombinant proteins, respectively (7) . The predicted size of an Li-encoded polypeptide is 57 kDa, which is consistent with the observed mobility of the major capsid protein upon sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). The predicted size of an L2-encoded polypeptide is 55 kDa. However, the observed mobility of the minor capsid protein has been reported to be between 76 and 86 kDa. It is unclear whether the observed mobility of the minor capsid protein is due to an inherent property of the L2-encoded polypeptide which causes it to migrate aberrantly upon SDS-PAGE or whether it is due to the addition of high-molecular-weight moieties to the L2 polypeptide through posttranslational modification.
To date, well-characterized monoclonal antibodies (MAbs) generated against HPV virions have not been described. Such reagents would be helpful in studies of virion capsid structure, HPV late-gene expression, and virion-cell interactions. In this report, we describe the characterization of murine polyclonal antisera and MAbs which were generated both against intact HPV type 1 (HPV1) virions and against SDS-denatured HPV1 virions. We also expressed the HPV1 Li and L2 coding sequences in the yeast Saccharomyces cerevisiae and by in vitro translation to determine whether Li-and L2-encoded polypeptides were equivalent in size to the major and minor capsid proteins of HPV1 virions, respectively. HPV1 virions were extracted from a single large plantar * Corresponding author.
wart (19) . Intact HPV1 virion particles and SDS-denatured HPV1 virions were used to prepare polyclonal antisera and MAbs in BALB/c mice (10) . Polyclonal antisera were prepared from the blood of each mouse at the time of sacrifice. Hybridoma culture supernatants were screened for antibody reactivities to intact HPV1 virions in an enzyme-linked immunosorbent assay (ELISA) and for reactivity with nuclear antigens in HPV1-containing plantar wart sections by immunohistochemical staining. Antibody specificities were further defined by testing the antibodies in Western immunoblot assays for reactivities with HPV Li-and L2-encoded polypeptides expressed in Escherichia coli (8, 13) . The locations of antibody-reactive epitopes were mapped by using nested sets of deleted HPV polypeptides (14) and by using overlapping sets of synthetic oligopeptides (9) . Forty-three of approximately 1,000 viable hybridomas prepared against intact HPV1 virion preparations produced antibodies which reacted with intact HPV1 virion preparations in an ELISA. Twenty-three of the ELISA-positive clones reacted with plantar wart epithelial cell nuclei and did not react with epithelial cells in sections of normal skin. Twelve of the 23 clones gave unambiguous reactions upon immunoglobulin isotyping, and these clones were selected for further study. These 12 MAbs were all immunoglobulin G2a (IgG2a) containing kappa light chains (mouse MAb isotyping kit; Amersham Corp., Arlington Heights, Ill.).
Approximately 1,000 hybridomas prepared against disrupted virions were tested as described above. Twenty-nine clones were ELISA positive, but only one of these clones (MAb DW45) gave strong nuclear staining of HPV1-containing tissue. MAb DW45 was IgG2b containing kappa light chains.
Polyclonal antisera were tested in Western immunoblot assays for IgG and IgM reactivities to HPVla Li and HPVla L2 polypeptides expressed as trpE-HPV fusion proteins in E. coli (3, 5, 6, 13, 20) (Table 1 and Fig. 1) . The results are shown in Fig. 2 (3, 5, 6, 20) . The boxes labeled A, B, and C mark the locations of coding sequences for the HPV1 L2 MAb-reactive epitope, the HPV1 Li MAb-reactive epitope, and a rabbit anti-BPV1 antibody reactive region, respectively. The DNA fragments present in the expression plasmids which defined the immunoreactive regions are indicated as lines below the ORFs. The nucleotide coordinates of the ends of the fragments are indicated (see Table 1 for a complete description of the expression plasmids and Fig. 3 (14) . Unidirectional 3'-to-5' deletions were made in' the HPV DNA ins'erts of the bacterial expression plasmids by using exonuclease III and nuclease S1 (S1) according to the protocol of Henikoff (11) . Plasm'ids derived from the exonuclease ITT-Si deletions expressed nested sets of fusion proteins sequentially deleted from the carboxy toward the amino terminus of the HPV-encoded polypeptide. The deleted fusion proteins were reacted with the antibodies in a Western immnunoblot assay to determine the carboxy boundary of the immunoreactive region (14) .
The HPVla L2 polypeptide segment recognized by all 12 MAbs generated against intact HPV1 virions mapped to the same location. The MAbs reacted with the p1L2Ex4222 fusion protein (3' end at HPV1a coordinate 4222) and la'rger fusio'n proteins and failed to react with the p1L2Ex4183 fusion protein (3' end at coordinate 4183) and smaller fusion proteins (Fig. 3) . This placed the 3' boundary of the immunoreactive region-coding segment between nucleotide (nt) 4183 and nt4222. This DNA segment encodes HPV1 L2 amino acids (aa) 95 through 108 (measured from the first L2 methionine codon). The HPV1 L2 epitope was further localized by reacting the MAbs in an ELISA with a set of overlapping peptides (hexamers) which spanned the region from aa88 through aali8 (9, 14) . The hexapeptides were synthesized on polyethylene pins by using a commercially available kit (9) (Epitope Scanning Kit; Cambridge Research Biochemicals, Wilmington, Del.). The MAbs reacted with two adjacent hexapeptides, one which included aalO2 to aalO7 and the other which included aalO3 to aalO8 (Fig. 3) mapped by using a n fusion proteins which were serially deleted from the carb the amino terminus (clones A through J). (A) Coom stained SDS-12.5% polyacrylamide gel of whole bacte which contain these fusion proteins (the positions of proteins are marked with arrows). (B) Replicate Westei blot which was reacted with MAb W275. The nucleotide of the 3' ends of the HPV1 L2 inserts in clones H and I a] (see also Fig. 1 (plLlEx5806) and nt5886 (plLlEx5886) (Fig. 4) , and further mapping localized the coding sequence between nt5812 and nt5851 (data not shown). This segment encodes HPVla Li aa127 through aal4O (measured from the second Li methionine codon). The HPV1 Li epitope was further localized by reacting the MAbs in an ELISA with a set of overlapping peptides (hexamers) which spanned the region from aal21 through aa147. The MAbs reacted with two adjacent hexapeptides, aai27 to aal32 and aai28 to aa133. Therefore, the HPV1 Ll-reactive MAbs recognized a linear amino acid sequence which lies between aal27 and aal33 (Ala-Glu-Asn-Pro-ThrAsn-Tyr).
The region of the HPVla Li polypeptide recognized by rabbit anti-BPV1 antiserum was further localized by deletion mapping to determine whether it was distinct from the DW45-reactive epitope. The carboxy-terminal boundary of the rabbit anti-BPVi reactivity mapped to the coding sequence between nt5998 and nt6045, which encodes HPV1 Li aai90 through aa205 (Fig. 4) . None of the fusion proteins which were deleted beyond aai90 reacted with the rabbit anti-BPV1 antiserum. Therefore, the rabbit anti-BPV1 reactive region(s) lies closer to the carboxy terminus of the Li polypeptide relative to the DW45-reactive region, and these regions do not overlap.
To determine whether Li-and L2-encoded polypeptides were consistent in size with the major and minor viral capsid proteins, respectively, we expressed the HPVla Li and L2 coding sequences (20) in the yeast S. cerevisiae (1, 2, 17) and by in vitro translation using a rabbit reticulocyte lysate. The HPV1 MAbs were used to immunoprecipitate the HPV1-encoded polypeptides from lysates of yeast cells which were grown in the presence of [35S]methionine (15 [35S]methionine. The Li polypeptide had an apparent molecular mass of 57 kDa and the L2 polypeptide had an apparent molecular mass of 91 kDa on an SDS-10% polyacrylamide gel (Fig. 5) . The Li-and L2-encoded polypeptides are consistent in size with the major and minor viral capsid proteins, respectively. Therefore, the aberrant mobility of the minor viral capsid protein upon SDS-PAGE appears to be due to an inherent property of the L2-encoded polypeptide and is not due to the addition of high-molecularweight moieties by posttranslational modification.
We demonstrated that a polyclonal antiserum generated in a BALB/c mouse against intact HPV1 virions contained type-specific antibodies directed against the L2-encoded minor capsid protein and contained no antibodies directed against linear epitopes of the Li-encoded major capsid protein. MAbs recognized a linear epitope between L2 aalO2 and aalO8 (PIDVVDP). These results suggest that HPV1 L2 aaiO2 through aalO8 are located on the external viral capsid surface and that they constitute an immunodominant linear epitope in BALB/c mice. A polyclonal antiserum generated in a BALB/c mouse against detergent-denatured HPV1 virions contained both HPV1 Li-and L2-reactive antibodies, and in each case these antibodies were relatively HPV type specific. Polyclonal antisera generated in rabbits against SDS-denatured HPV virions have generally included Lireactive antibodies which broadly cross-react with other NOTES papillomavirus types (14, 16) . The lack of such antibodies in the BALB/c mouse immunized with SDS-denatured HPV1 virions may indicate that, unlike rabbits, the BALB/c mouse did not generate an antibody response to a linear Li epitope which is highly conserved among papillomaviruses.
